These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25512202)

  • 21. Pupil cycle time: as indicator of visual pathway dysfunction in multiple sclerosis.
    Karahan E; Karti O; Koskderelioglu A; Karti DT; Uyar M; Kale MY; Gedizlioglu M
    Acta Neurol Belg; 2017 Mar; 117(1):75-81. PubMed ID: 28054250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Retinal atrophy using optical coherence tomography (OCT) in 15 patients with multiple sclerosis and comparison with healthy subjects].
    Jeanjean L; Castelnovo G; Carlander B; Villain M; Mura F; Dupeyron G; Labauge P
    Rev Neurol (Paris); 2008 Nov; 164(11):927-34. PubMed ID: 18808761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurophysiological, radiological and neuropsychological evaluation of fatigue in multiple sclerosis.
    Chalah MA; Kauv P; Créange A; Hodel J; Lefaucheur JP; Ayache SS
    Mult Scler Relat Disord; 2019 Feb; 28():145-152. PubMed ID: 30594815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
    Krause I; Kern S; Horntrich A; Ziemssen T
    Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.
    Garcia-Martin E; Rodriguez-Mena D; Herrero R; Almarcegui C; Dolz I; Martin J; Ara JR; Larrosa JM; Polo V; Fernández J; Pablo LE
    Neurology; 2013 Jul; 81(1):76-83. PubMed ID: 23709591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?
    Di Maggio G; Santangelo R; Guerrieri S; Bianco M; Ferrari L; Medaglini S; Rodegher M; Colombo B; Moiola L; Chieffo R; Del Carro U; Martinelli V; Comi G; Leocani L
    Mult Scler; 2014 Sep; 20(10):1342-7. PubMed ID: 24591532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
    Baier ML; Cutter GR; Rudick RA; Miller D; Cohen JA; Weinstock-Guttman B; Mass M; Balcer LJ
    Neurology; 2005 Mar; 64(6):992-5. PubMed ID: 15781814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients.
    Garcia-Martin E; Pueyo V; Almarcegui C; Martin J; Ara JR; Sancho E; Pablo LE; Dolz I; Fernandez J
    Br J Ophthalmol; 2011 Nov; 95(11):1577-82. PubMed ID: 21785155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capturing saccades in multiple sclerosis with a digitized test of rapid number naming.
    Hainline C; Rizzo JR; Hudson TE; Dai W; Birkemeier J; Raynowska J; Nolan RC; Hasanaj L; Selesnick I; Frohman TC; Frohman EM; Galetta SL; Balcer LJ; Rucker JC
    J Neurol; 2017 May; 264(5):989-998. PubMed ID: 28389741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients.
    Benito-León J; Morales JM; Rivera-Navarro J
    Eur J Neurol; 2002 Sep; 9(5):497-502. PubMed ID: 12220381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis.
    Haase CG; Tinnefeld M; Faustmann PM
    Neuroimmunomodulation; 2004; 11(6):365-72. PubMed ID: 15467351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of depression, fatigue and disability on quality of life in Chinese patients with multiple sclerosis.
    Chen K; Fan Y; Hu R; Yang T; Li K
    Stress Health; 2013 Apr; 29(2):108-12. PubMed ID: 22566371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atrophy of the retinal nerve fibre layer in multiple sclerosis patients. Prospective study with two years follow-up].
    García-Martín E; Pueyo V; Fernández J; Almárcegui C; Dolz I; Martín J; Ara JR; Honrubia FM
    Arch Soc Esp Oftalmol; 2010 May; 85(5):179-86. PubMed ID: 23010522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiety, emotional processing and depression in people with multiple sclerosis.
    Gay MC; Bungener C; Thomas S; Vrignaud P; Thomas PW; Baker R; Montel S; Heinzlef O; Papeix C; Assouad R; Montreuil M
    BMC Neurol; 2017 Feb; 17(1):43. PubMed ID: 28231828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis.
    Weinstock-Guttman B; Baier M; Stockton R; Weinstock A; Justinger T; Munschauer F; Brownscheidle C; Williams J; Fisher E; Miller D; Rudick R
    Mult Scler; 2003 Oct; 9(5):529-34. PubMed ID: 14582782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
    Labiano-Fontcuberta A; Mitchell AJ; Moreno-García S; Benito-León J
    J Neurol Sci; 2015 Feb; 349(1-2):220-5. PubMed ID: 25638658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visual Pathway Measures are Associated with Neuropsychological Function in Multiple Sclerosis.
    Nguyen J; Rothman A; Fitzgerald K; Whetstone A; Syc-Mazurek S; Aquino J; Balcer LJ; Frohman EM; Frohman TC; Crainiceanu C; Beier M; Newsome SD; Calabresi PA; Saidha S
    Curr Eye Res; 2018 Jul; 43(7):941-948. PubMed ID: 29634379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
    Kallaur AP; Lopes J; Oliveira SR; Simão AN; Reiche EM; de Almeida ER; Morimoto HK; de Pereira WL; Alfieri DF; Borelli SD; Kaimen-Maciel DR; Maes M
    Mol Neurobiol; 2016 Oct; 53(8):5191-202. PubMed ID: 26399644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of pain in patients with multiple sclerosis and its association with anxiety, depressive symptoms and quality of life.
    Łabuz-Roszak B; Niewiadomska E; Kubicka-Bączyk K; Skrzypek M; Tyrpień-Golder K; Majewska A; Matejczyk A; Dobrakowski P; Pierzchała K
    Psychiatr Pol; 2019 Apr; 53(2):475-486. PubMed ID: 31317971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.